Unknown

Dataset Information

A novel nickel complex works as a proteasomal deubiquitinase inhibitor for cancer therapy.


ABSTRACT: Based on the central role of the ubiquitin-proteasome system (UPS) in the degradation of cellular proteins, proteasome inhibition has been considered an attractive approach for anticancer therapy. Deubiquitinases (DUBs) remove ubiquitin conjugates from diverse substrates; therefore, they are essential regulators of the UPS. DUB inhibitors, especially the inhibitors of proteasomal DUBs are becoming a research hotspot in targeted cancer therapy. Previous studies have shown that metal complexes, such as copper and zinc complexes, can induce cancer cell apoptosis through inhibiting UPS function. Moreover, we have found that copper pyrithione inhibits both 19S proteasome-associated DUBs and 20S proteasome activity with a mechanism distinct from that of the classical 20S proteasome inhibitor bor

SUBMITTER: Zhao C 

PROVIDER: S-EPMC5497060 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature